Status:
UNKNOWN
Botulinum Toxin Injection in Patients Undergoing Hemorrhoidectomy-A Prospective, Randomized Study
Lead Sponsor:
Tri-Service General Hospital
Conditions:
The Influence of Timing of Botulinum Toxin Injection on Postoperative Pain Control
Eligibility:
All Genders
20-80 years
Phase:
PHASE4
Brief Summary
This is a prospective, randomized study, which anticipatedly recruited 60 patients in the outpatient department who need hemorrhoidectomy from January 2019 to December 2019. After obtaining those pati...
Eligibility Criteria
Inclusion
- patients with age over 20 but under 80, who need to undergo hemorrhoidectomy
Exclusion
- patients under the age of 20
- patients with nonsteroidal anti-inflammatory drugs (NSAIDs) allergy or sensitivity
- patients with Botulinum toxin allergy or sensitivity
- patients with dialysis or renal insufficiency
- pregnant and breastfeeding women
- vulnerable population
Key Trial Info
Start Date :
October 8 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04485780
Start Date
October 8 2018
End Date
December 31 2021
Last Update
July 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tri-Service General Hospital, National Defense Medical Center
Taipei, Taiwan